← Back to headlines
Revolution Medicines Receives FDA’s “Safe to Proceed” Letter for Daraxonrasib
Revolution Medicines (RVMD) has received a "Safe to Proceed" letter from the FDA for its drug candidate Daraxonrasib, indicating regulatory approval to advance its development.
10 May, 23:14 — 10 May, 23:14
Sources
Showing 1 of 1 sources
Related Stories
Oldest Known Plague Outbreak Discovered in Siberia Dating Back 5,500 Years
just now
Extreme Training: What Heat Training Does to the Body
just now
European Heatwave Death Toll Rises to Thousands, Germany Reports Elderly Most Affected
17m ago
Veterinarians Warn Dog Owners About Arthritis Risk in Popular Breeds
28m ago